Hexo Perhaps a Good Comparison to ENTGHexo is losing $1.99 per share, has only twice the revenues yet 5x the loss in comparison to ENTG, but sits at about $2.00 per share. Similar to the now estabished 5 year contractual relationship Entourage has with Boston Beer, Hexo is working with Molson Coors.
As an aside, Hexo press releases strike me as not nearly as regular, well written, transparent or rich with detail.
In the case of Entourage, they will soon be realizing massive additional revenues and profits from the sale of cannabis for cannabis beverage production, and for exclusive distribution throughout Canada of the final product. Little infrastructure investment is required for this major cooperative venture, as they add even further dimension to their now well established reliable tapestry of products.
It is important also to remember that they have have a special license to sell directly to the general public sans the middleman including to the union members serviced by Starseed (and often paid for by Government Health in Canada); and also have distribution networks in 95% of Canada. No doubt distribution was an important factor for Boston Beer in establishing a 5 year contract with them.
Some folks seem concerned about the CannTx acquisition. I am not even convinced it would be a good idea as ENTG already has such a diversified portfolio of reputed cannabis products and production contracts including with Fire an Flower, Mary's Medicinals, Pax, and Boston Beer.